AU2623795A - Immunogenic pharmaceuticals - Google Patents
Immunogenic pharmaceuticalsInfo
- Publication number
- AU2623795A AU2623795A AU26237/95A AU2623795A AU2623795A AU 2623795 A AU2623795 A AU 2623795A AU 26237/95 A AU26237/95 A AU 26237/95A AU 2623795 A AU2623795 A AU 2623795A AU 2623795 A AU2623795 A AU 2623795A
- Authority
- AU
- Australia
- Prior art keywords
- immunogenic
- pharmaceuticals
- immunogenic pharmaceuticals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9410922A GB9410922D0 (en) | 1994-06-01 | 1994-06-01 | Vaccines |
GB9410922 | 1994-06-01 | ||
PCT/GB1995/001274 WO1995032731A2 (en) | 1994-06-01 | 1995-06-01 | Immunogenic pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2623795A true AU2623795A (en) | 1995-12-21 |
Family
ID=10755982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26237/95A Abandoned AU2623795A (en) | 1994-06-01 | 1995-06-01 | Immunogenic pharmaceuticals |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0762891A1 (en) |
JP (1) | JPH10504702A (en) |
AU (1) | AU2623795A (en) |
GB (1) | GB9410922D0 (en) |
WO (1) | WO1995032731A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958684A (en) * | 1995-10-02 | 1999-09-28 | Van Leeuwen; Frederik Willem | Diagnosis of neurodegenerative disease |
WO1998045322A2 (en) * | 1997-04-10 | 1998-10-15 | Royal Netherlands Academy Of Arts And Sciences | Diagnosis method and reagents |
NO314086B1 (en) * | 1998-05-08 | 2003-01-27 | Gemvax As | Peptides and pharmaceutical compositions containing them, nucleic acid sequences encoding such peptides, plasmids and virus vectors encompassing such DNA sequences and their use for the preparation of pharmaceutical preparations for |
NO315238B1 (en) | 1998-05-08 | 2003-08-04 | Gemvax As | Peptides derived from reading frame shift mutations in the TBF <beta> II or BAX gene, and pharmaceutical compositions containing them, nucleic acid sequences encoding such peptides, plasmids, and virus vector-encompassing such nucleic acid |
ITMI20030434A1 (en) * | 2003-03-07 | 2004-09-08 | Istituto Oncologico Romagnolo Coope Rativa Sociale | METHOD FOR THE DETECTION OF COLON-RECTUM TUMORS. |
EP1994181A4 (en) * | 2006-02-27 | 2010-05-19 | Univ Arizona | Identification and use of novopeptides for the treatment of cancer |
US9732131B2 (en) | 2006-02-27 | 2017-08-15 | Calviri, Inc. | Identification and use of novopeptides for the treatment of cancer |
EP3075389A1 (en) * | 2015-03-31 | 2016-10-05 | Technische Universität München | T cell receptors and peptides derived by mutations for the treatment of cancer |
CN108495649A (en) | 2016-01-08 | 2018-09-04 | 瓦西博迪公司 | The new epiposition vaccine of therapeutic anti-cancer |
EP3630130B1 (en) | 2017-06-02 | 2022-08-31 | Arizona Board of Regents on behalf of Arizona State University | A method to create personalized cancer vaccines |
GB201710812D0 (en) * | 2017-07-05 | 2017-08-16 | Francis Crick Inst Ltd | Method |
US12025615B2 (en) | 2017-09-15 | 2024-07-02 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of classifying response to immunotherapy for cancer |
WO2020022903A1 (en) | 2018-07-26 | 2020-01-30 | Frame Pharmaceuticals B.V. | ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER |
EP3827262A1 (en) | 2018-07-26 | 2021-06-02 | Frame Pharmaceuticals B.V. | Cancer vaccines for breast cancer |
WO2020022900A1 (en) | 2018-07-26 | 2020-01-30 | Frame Pharmaceuticals B.V. | Cancer vaccines for kidney cancer |
US12005104B2 (en) | 2018-07-26 | 2024-06-11 | Curevac Netherlands B.V. | Cancer vaccines for colorectal cancer |
EP3826669A2 (en) | 2018-07-26 | 2021-06-02 | Frame Pharmaceuticals B.V. | Off-the-shelf cancer vaccines |
CA3106570A1 (en) | 2018-07-26 | 2020-01-30 | Frame Pharmaceuticals B.V. | Cancer vaccines for uterine cancer |
EP4038222A4 (en) | 2019-10-02 | 2023-10-18 | Arizona Board of Regents on behalf of Arizona State University | Methods and compositions for identifying neoantigens for use in treating and preventing cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4687737A (en) * | 1982-11-12 | 1987-08-18 | Massachusetts Institute Of Technology | Mammalian suppressor genes |
EP0565794A1 (en) * | 1992-04-14 | 1993-10-20 | British Biotech Pharmaceuticals Limited | Induction of CTL responses |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
-
1994
- 1994-06-01 GB GB9410922A patent/GB9410922D0/en active Pending
-
1995
- 1995-06-01 JP JP8500539A patent/JPH10504702A/en active Pending
- 1995-06-01 EP EP95921028A patent/EP0762891A1/en not_active Withdrawn
- 1995-06-01 AU AU26237/95A patent/AU2623795A/en not_active Abandoned
- 1995-06-01 WO PCT/GB1995/001274 patent/WO1995032731A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1995032731A2 (en) | 1995-12-07 |
GB9410922D0 (en) | 1994-07-20 |
JPH10504702A (en) | 1998-05-12 |
EP0762891A1 (en) | 1997-03-19 |
WO1995032731A3 (en) | 1995-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3532195A (en) | Medicaments | |
AU3304795A (en) | Bisresorcinyltriazines | |
AU2832295A (en) | Cytoanalyzer | |
AU3304995A (en) | 2-Hydroxyphenyltriazines | |
AU2623795A (en) | Immunogenic pharmaceuticals | |
AU2837895A (en) | Thiazine- or thiazepine-derivatives | |
AU4131596A (en) | Polyglycomers | |
AU4044795A (en) | Handleset | |
AU2308295A (en) | Heterocyclylbenzonitriles | |
AU1963395A (en) | Boom-structure | |
AU4029295A (en) | Thienopyridones | |
AU1475595A (en) | Pharmaceutical preparation | |
AU3991695A (en) | Ranging system | |
AU7469594A (en) | Poop-scoop | |
AU3166195A (en) | Acylimidazopyridines | |
AU4590996A (en) | Boekomslag | |
AUPM365494A0 (en) | Pre-chiller | |
AU2411395A (en) | Hydrocopter | |
AU3166095A (en) | Benzylimidazopyridines | |
AU6409894A (en) | Recognin vaccines | |
AU1603595A (en) | Meso-azanoradamantanes | |
AU3446995A (en) | Biodestumping | |
AU3417395A (en) | Hydro-ethano-indeno-pyridines | |
AUPM374794A0 (en) | Compartmentalizer | |
AU658811B3 (en) | Bum-bag |